Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access program

Authors:

Abstract
No abstract available
Funding Information
  • Chiesi Farmaceutici
  • Università degli Studi di Palermo
  • Aegerion Pharmaceuticals

This publication has 21 references indexed in Scilit: